Table: begin end state 1 11 cytoplasmic 12 30 transmembrane 31 48 non-cytoplasmic 49 71 transmembrane 72 80 cytoplasmic 81 104 transmembrane 105 105 non-cytoplasmic 106 130 transmembrane 131 140 cytoplasmic 141 162 transmembrane 163 167 non-cytoplasmic 168 188 transmembrane 189 232 cytoplasmic 233 254 transmembrane 255 269 non-cytoplasmic 270 289 transmembrane 290 299 cytoplasmic 300 318 transmembrane 319 323 non-cytoplasmic 324 347 transmembrane 348 356 cytoplasmic 357 379 transmembrane 380 390 non-cytoplasmic 391 410 transmembrane 411 432 cytoplasmic
Input: >Pf6N2E2_628 2-ketogluconate transporter MQTLNLATRRWWYIMPIVFITYSLAYLDRANYGFAAASGMAKDLMITPGLSSLLGALFFL GYFFFQVPGAIYAQKHSVKKLIFVSLILWGSLATLTGVVSNAYWLIVIRFMLGVVEAAVM PAMLVYLCHWFTRAERSRANTFLILGNPVTMLWMSVVSGYLVQQFDWRWMFIIEGLPAVL WAFIWWRLADDRPSQAKWLSDQEKHDLESALAAEQVGIKAVKNYAEAFRSPKVIILALQF FCWSIGVYGFVLWLPSILKAGLQMNMVEAGWLSSLPYLAAVIGMLVVSWASDKAQKRKRF VWPPLLVASIAFYASYLLGPEHFWWSYSLLVVAGACMYAPYGPFFAIVPEILPANVAGGA MALINSMGALGSFGGSYLVGYLNGSTGSPGMSFLLMSGALLVAVVLTLALKPGASDRVLS KTATPHSAPAHS
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server